Quizartinib inhibits necroptosis by targeting receptor-interacting serine/threonine protein kinase 1.
FASEB J
; 37(10): e23178, 2023 10.
Article
in En
| MEDLINE
| ID: mdl-37698367
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Tumor Necrosis Factor-alpha
/
Receptor-Interacting Protein Serine-Threonine Kinases
/
Necroptosis
Type of study:
Prognostic_studies
Limits:
Animals
Language:
En
Journal:
FASEB J
Journal subject:
BIOLOGIA
/
FISIOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: